Physician profile
Sonia Sood
NPI 1699747592
$889.98
in general payments reported to CMS, 2019-2025
17 companies · $46.20 in 2025
The $46.20 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2022: $40.36 · 2023: $164 · 2024: $43.55 · 2025: $46.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $213.26 | 2019 | |
| Pfizer INC. | $138.60 | 2019-2024 | |
| Inspire Medical Systems, INC. | $101.97 | 2023 | Inspire |
| Exact Sciences Corporation | $87.35 | 2023-2025 | Cologuard Collection Kit |
| Medtronic Vascular, INC. | $58.44 | 2019 | |
| Novo Nordisk INC | $54.97 | 2019-2023 | Wegovy |
| Lilly USA, LLC | $44.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $41.95 | 2019-2022 | |
| Genentech USA, INC. | $22.93 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.76 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.86 | 2019 | |
| Allergan, INC. | $17.78 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.77 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.67 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.63 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.